February 08, 2024
It's Thursday and we wanted to wrap up your day with our quick take on what Cathy McMorris Rodgers' retirement means for health care, and what's next.
1 big thing: CMR's exit clouds health outlook
McMorris Rodgers during an E&C hearing. Photo: Chip Somodevilla/Getty Images
House Energy and Commerce Chair Cathy McMorris Rodgers' retirement casts uncertainty over the fate of House's transparency package, post-COVID oversight of federal health agencies and legislation addressing disability rights.
The big picture: The health cost transparency package may be seen as her signature health achievement, which includes narrow site-neutral measures, PBM transparency provisions and new requirements on hospitals and insurers.
What's next: E&C health subcommittee chair Brett Guthrie's spokesman confirmed to Axios that he will run for the full committee chairmanship.
- Another name that lobbyists floated was Rep. Bob Latta, who's another senior member of the committee.
Between the lines: Rodgers joins two other prominent E&C members who were active on health policy and are departing at the end of this Congress: Reps. Michael Burgess and Larry Bucshon.
- McMorris Rodgers notched some bipartisan wins, as with the transparency package. But she also held the GOP line by, for example, resisting calls to address drug shortages in a pandemic preparedness reauthorization.
- This month she also subpoenaed NIH for documents and information related its handling of sexual harassment complaints within the agency and its grantee institutions.
What we're watching: Whether CMR's early retirement announcement will weaken her hand in negotiations with the Senate over a transparency package, or on other health priorities, such as PAHPA, telehealth programs and Medicare payment reform.
✅ Thank you for reading Axios Pro Policy, and thanks to editors Adriel Bettelheim and David Nather.
- Do you know someone who needs this newsletter? Have them sign up here.
View archive
